Natural History of Multiple System Atrophy in North America: A Prospective Cohort Study

[1]  G. Wenning,et al.  Multiple System Atrophy , 2014, CNS drugs.

[2]  J. Parisi,et al.  Multiple system atrophy: Prognostic indicators of survival , 2014, Movement disorders : official journal of the Movement Disorder Society.

[3]  K. Jellinger,et al.  Towards translational therapies for multiple system atrophy , 2014, Progress in Neurobiology.

[4]  S. Gilman,et al.  Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial , 2014, The Lancet Neurology.

[5]  Günther Deuschl,et al.  The natural history of multiple system atrophy: a prospective European cohort study , 2013, The Lancet Neurology.

[6]  S. Gilman,et al.  Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  E. Masliah,et al.  Multiple system atrophy: a clinical and neuropathological perspective , 2011, Trends in Neurosciences.

[8]  Albert C. Ludolph,et al.  Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE , 2011, PloS one.

[9]  Sid Gilman,et al.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. , 2009, Archives of neurology.

[10]  Y. Agid,et al.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study , 2008, Brain : a journal of neurology.

[11]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[12]  J. Jankovic,et al.  Potential outcome measures and trial design issues for multiple system atrophy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[13]  M. T. Pellecchia,et al.  Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[14]  F. Kopper,et al.  The European Multiple System Atrophy-Study Group (EMSA-SG) , 2005, Journal of Neural Transmission.

[15]  Sid Gilman,et al.  Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[16]  Y. Abe,et al.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. , 2002, Brain : a journal of neurology.

[17]  H U Rehman,et al.  Multiple system atrophy , 2001, Postgraduate medical journal.

[18]  K. Offord,et al.  The Autonomic Symptom Profile , 1999, Neurology.

[19]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[20]  D. Maraganore,et al.  Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990 , 1997, Neurology.

[21]  P. Sandroni,et al.  Autonomic involvement in extrapyramidal and cerebellar disorders , 1991, Clinical Autonomic Research.

[22]  K. K. Snow,et al.  Sf-36r Health Survey Manual And Interpretation Guide , 2015 .

[23]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .